This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Effect of Advertisements on Treatment Compliance in Women With Breast Cancer

This study has been completed.
Information provided by:
National Cancer Institute (NCI) Identifier:
First received: April 18, 2007
Last updated: January 20, 2012
Last verified: May 2011

RATIONALE: Measuring how advertising affects treatment compliance in women with breast cancer may help doctors plan the best treatment.

PURPOSE: This clinical trial is studying how advertisements affect treatment compliance in women with breast cancer.

Condition Intervention
Breast Cancer Other: counseling intervention Procedure: psychosocial assessment and care

Study Type: Interventional
Study Design: Masking: Open Label
Primary Purpose: Health Services Research
Official Title: Socio-anthropological Study Evaluating the Impact of Observance or Treatment in Patients With Breast Cancer

Resource links provided by NLM:

Further study details as provided by National Cancer Institute (NCI):

Primary Outcome Measures:
  • Treatment compliance

Secondary Outcome Measures:
  • Factors affecting adherence to the medical plan

Estimated Enrollment: 65
Study Start Date: March 2006
Primary Completion Date: May 2011 (Final data collection date for primary outcome measure)
Detailed Description:



  • Evaluate the consequences of advertisement on treatment compliance in women with breast cancer.


  • Determine the factors favoring or not favoring adherence to the medical recommendations.

OUTLINE: Patients and their medical and nonmedical caregivers are interviewed by a sociologist or anthropologist twice over 1 year. The first interview is at the consultation visit and the second interview is at the patient's home. The impact of advertisement on treatment compliance is measured.

PROJECTED ACCRUAL: A total of 65 patients will be accrued for this study.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No


  • Diagnosis of breast cancer
  • Hormone receptor status not specified


  • Female
  • Menopausal status not specified


  • Not specified
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00462410

Sponsors and Collaborators
Institut Bergonié
Study Chair: Marc Debled, MD Institut Bergonié
  More Information Identifier: NCT00462410     History of Changes
Other Study ID Numbers: CDR0000540528
Study First Received: April 18, 2007
Last Updated: January 20, 2012

Keywords provided by National Cancer Institute (NCI):
recurrent breast cancer
stage I breast cancer
stage II breast cancer
stage IIIA breast cancer
stage IIIB breast cancer
stage IIIC breast cancer
stage IV breast cancer

Additional relevant MeSH terms:
Breast Neoplasms
Neoplasms by Site
Breast Diseases
Skin Diseases processed this record on July 26, 2017